Results 171 to 180 of about 49,920 (311)
The depression of myotonic dystrophy: response to imipramine. [PDF]
Roger A. Brumback, Kenneth M. Carlson
openalex +1 more source
Oral side effects of fluoxetine in patients with depressive disorder: A systematic review. [PDF]
Sarrión Pérez MG+3 more
europepmc +1 more source
Retraction Note: Disruption of lipid-raft localized Gαs/tubulin complexes by antidepressants: a unique feature of HDAC6 inhibitors, SSRI and tricyclic compounds. [PDF]
Singh H+3 more
europepmc +1 more source
Treatment of imipramine-induced hyperpigmentation with quality-switched ruby and picosecond lasers
Ramiz Nayyer Hamid, MD, MPH+2 more
doaj
Long‐term imipramine treatment enhances locomotor and food intake suppressant effects of m‐chlorophenylpiperazine in rats [PDF]
Charanjit S. Aulakh+4 more
openalex +1 more source
The Anti-Inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology. [PDF]
Eslami M+6 more
europepmc +1 more source
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and memory loss. Imipramine, a tricyclic antidepressant, has potent anti-inflammatory and antioxidant properties in the central nervous system. The aim
Alireza Jamshidi Hasanabadi+3 more
doaj